Department of Colorectal Oncology, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Department of Hepatobiliary Oncology, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin's Clinical Research Center for Cancer, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, China.
Crit Rev Oncol Hematol. 2023 Aug;188:104057. doi: 10.1016/j.critrevonc.2023.104057. Epub 2023 Jun 14.
We analyzed the somatic mutation distributions as well as pathways associated with liver/lung metastasis of CRC using next-generation sequencing panel.
We detected the somatic SNV/indel mutations of 1126 tumor-related genes in CRC, liver/lung metastasis of CRC and liver /lung cancer. We combined the MSK and GEO datasets to identified the genes and pathways related to the metastasis of CRC.
We identified 174 genes related to liver metastasis of CRC, 78 genes related to lung metastasis of CRC, and 57 genes related to both liver and lung metastasis in two datasets. The genes related to liver and lung metastasis were collectively enriched in various pathways. Finally we found that IRS1, BRCA2, EphA5, PTPRD, BRAF, and PTEN could be prognosis-related genes in CRC metastasis.
Our finding may help clarify the pathogenesis of CRC metastasis more clearly and provide new perspectives for the diagnosis and treatment of CRC metastasis.
我们使用下一代测序 panel 分析了 CRC 肝/肺转移相关的体细胞突变分布以及通路。
我们检测了 CRC、CRC 肝/肺转移和肝/肺癌中 1126 个肿瘤相关基因的体细胞 SNV/indel 突变。我们结合 MSK 和 GEO 数据集,确定了与 CRC 转移相关的基因和通路。
我们在两个数据集中共鉴定出 174 个与 CRC 肝转移相关的基因、78 个与 CRC 肺转移相关的基因和 57 个与肝和肺转移均相关的基因。与肝和肺转移相关的基因在各种通路中被共同富集。最后我们发现 IRS1、BRCA2、EphA5、PTPRD、BRAF 和 PTEN 可能是 CRC 转移的预后相关基因。
我们的发现可能有助于更清楚地阐明 CRC 转移的发病机制,并为 CRC 转移的诊断和治疗提供新的视角。